A new standard of drug research and development

New research commissioned by Proscia asked 40 senior executives at the top 150 pharma companies and leading contract research organizations about their use of digital pathology, the benefits it has delivered, and its future impacts.

The results collectively indicate a growing need to unify teams, applications (including AI), and pathology data with a modern software platform that drives all stages of R&D across the connected enterprise.

Download the survey report to learn how the respondents viewed:

  • The state of digital pathology adoption in life sciences
  • Top reasons for going digital
  • The growing use of AI to drive efficiency and quality gains

Get Your Copy

Please use a valid email


About Proscia

Proscia is a software company that is accelerating pathology’s transformation toward a data-driven discipline. Our Concentriq® digital pathology platform and powerful AI applications are unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care.